University City Science Center, a Philadelphia-based nonprofit, launched a new accelerator for technology-enabled startups. The first seven companies in its cohort will bring their technical expertise to healthcare.
Austin med device startup Spot On Sciences just won 10 grand and the winning spot at the Kauffman Foundation pitchfest, “Get in the Ring: The North American Startup Clash.” It sparred with seven other startups for the title, the cash, and a trip to the Netherlands to compete in the competition’s global finals. Spot On Sciences has […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Entrepreneurs are feeling as good as they have in over a year about the prospects for their early-stage companies. According to the Startup Confidence Index for Q1 2013, 84 percent of entrepreneurs said they are confident their profitability would increase within the next year — the highest confidence level they’ve shown since the Ewing Marion […]
When it comes to entrepreneurial hubs and good places to start a business, reports that name Silicon Valley and Boston as technology and healthcare clusters are only telling part of the story. Those places may have the greatest volume of health and technology companies, but from another angle, cities like Salt Lake City, Utah, and […]
The 2-and-20 compensation structure for venture capital funds is a one-size-fits-all approach that misaligns incentives and can help VCs to get paid handsomely while their funds perform abysmally. That was one conclusion from a much–discussed report on the venture capital industry from the Kauffman Foundation last month. “It’s interesting that VCs have positioned themselves as […]
Life science startups face more complex and daunting hurdles than new enterprises in non-regulated industries do. To help aspiring and early-stage life science entrepreneurs address these challenges, the Ewing Marion Kauffman Foundation will hold a Kauffman Life Science Ventures Summit June 22-23, 2012. The Foundation announced a call for applications today for the inaugural Summit, scheduled at the Mission Bay Conference Center at the University of California-San Francisco.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.